ABSTRACT Nutritional modulation of the immune system is an often exploited but poorly characterized process. In chickens and other food production animals, dietary enhancement of the immune response is an attractive alternative to antimicrobial use. A yeast cell wall component, β-1,3/1,6-glucan, augments the response to disease in poultry and other species; however, the mechanism of action is not clear. Ascorbic acid and corticosterone are better characterized immunomodulators. In chickens, the spleen acts both as reservoir and activation site for leukocytes and, therefore, splenic gene expression reflects systemic immune function. To determine effects of genetic line and dietary immunomodulators, chickens of outbred broiler and inbred Leghorn and Fayoumi lines were fed either a basal diet or an experimental diet containing β-glucans, ascorbic acid, or corticosterone from 56 to 77 d of age. Spleens were harvested, mRNA was isolated, and expression of interleukin (IL)-4, IL-6, IL-18, macrophage inflammatory protein-1β, interferon-γ, and phosphoinositide 3-kinase p110γ transcripts was measured by quantitative reverse transcription PCR. Effects of diet, genetic line, sex, and diet × genetic line interaction on weight gain and gene expression were analyzed. At 1, 2, and 3 wk after starting the diet treatments, birds fed the corticosterone diet had gained less weight compared with birds fed the other diets (P < 0.001). Sex affected expression of IL-18 (P = 0.010), with higher levels in males. There was a significant interaction between genetic line and diet on expression of IL-4, IL-6, and IL-18 (P = 0.021, 0.006, and 0.026, respectively). Broiler line gene expression did not change in response to the experimental diet. Splenic expression of IL-6 was higher in Leghorns fed the basal or ascorbic acid diets, rather than the β-glucan or corticosterone diets, whereas the opposite relationship was observed in the Fayoumi line. Expression of IL-4 and IL-18 responded to diet only within the Fayoumi line. The differential splenic expression of birds from diverse genetic lines in response to nutritional immunomodulation emphasizes the need for further study of this process.
INTRODUCTION
Disease resistance is a complex trait that is influenced by genetics, environment, and diet. Enhancing innate resistance to pathogens in chickens is of increasing interest as an alternative to antimicrobial use. Genetic selection for immune traits can increase general and specific resistance to pathogens in chickens (Janss and Bolder, 2000; Pinard-van der Laan, 2002; Lamont et al., 2003; Swaggerty et al., 2008) . Different lines and breeds of chickens have measureable differences in immune gene expression to pathogens (Kaiser et al., 2003; Cheeseman et al., 2007; Redmond et al., 2009) . Genetic resistance, however, is rarely completely protective and use of additional means to protect health, such as dietary immunomodulation, should be explored. Dietary enhancement of immune response can be accomplished via many different mechanisms, such as providing sufficient levels of nutrients to facilitate the immune response or altering the intestinal environment (Klasing, 1998; Kidd, 2004) . Studies of dietary immune modulation in chickens have evaluated supplements in individual genetic lines (Gross, 1992a,b; Sahin et al., 2003; Shini et al., 2008a; Chen et al., 2008) ; however, we are not aware of published tests of dietary immunomodulator efficacy across genetic lines. Most studies have focused on short-term (less than 2 wk) supplementation to allay the negative effects of stress or pathogen challenge (Gross, 1992a; McKee et al., 1997; Huff et al., 2006) ; however, the nature of commercial feeding programs makes longer term efficacy of dietary immune enhancers an important consideration. For this experiment, diets with corticosterone, β-glucans, or ascorbic acid immunomodulators were fed for a 3-wk period.
Corticosterone is a hormone released in response to physiological or environmental stress (Mumma et al., 2006) and pathogenic stimuli (Nakamura et al., 1998) , which binds intracellularly to the glucocorticoid receptor and affects regulation of nuclear factor-κB (NF-κB) and transcription of specific genes (Caldenhoven et al., 1995; Beato and Sánchez-Pacheco, 1996; Schaaf and Cidlowski, 2003) . In chickens, corticosterone release is followed by an increase in the relative proportion of heterophils to lymphocytes in circulation (Gross and Siegel, 1983 ). This increase is also observed in birds receiving corticosterone orally (Gross, 1992b; Post et al., 2003; Shini et al., 2008a) , which raises levels of plasma corticosterone within hours of treatment. Morphological changes in heterophils and lymphocytes persist for at least 10 d after initial exposure (Shini et al., 2008a) . Broilers exposed to corticosterone orally during the growing period show a reduced rate of gain proportionate to the level of corticosterone treatment, and high levels of corticosterone treatment reduce production of specific antibodies (Post et al., 2003; Shini et al., 2008b) . Oral corticosterone treatment has also been associated with increased expression of interleukin (IL)-6 and IL-18 in lymphocytes at 3 h after treatment started, with IL-18 levels remaining elevated 1 wk after the start of treatment (Shini and Kaiser, 2008) .
β-Glucans are a polysaccharide component of fungal cells walls and a pathogen-associated molecular pattern, which can be recognized by the innate immune system (Volman et al., 2008; Goodridge et al., 2009 ). In murine macrophages, recognition of β-glucans by the membrane receptor dectin-1 is followed by activation of Src and Syk kinases (Underhill et al., 2005) , mediating cellular activities such as phagocytosis and oxidative burst (Herre et al., 2004) as well as affecting the NF-κB immune regulatory pathway via interaction with toll-like receptors (Gantner et al., 2003 ). An equivalent mechanism is present in chicken heterophils, and stimulation of the dectin-1-like receptor results in increased production of reactive oxygen species (Nerren and Kogut, 2009); however, the associated genomic sequence has not yet been reported. The β-1,3/1,6-glucans of Saccharomyces cerevisiae have been shown to maintain growth in broiler chicks challenged with Escherichia coli (Huff et al., 2006) , increase heterophil activity to combat Salmonella Enteritidis (Lowry et al., 2005) , and increase nutrient retention (Chae et al., 2006) and height of jejunal villi (Morales-López et al., 2009 ) in young broilers. Studies of β-glucans fed to other species have shown treatment to increase rat neutrophil migration to wound and infection sites (LeBlanc et al., 2006) , minnow neutrophil degranulation (Palić et al., 2006) , and trout antibody production in response to vaccination (Verlhac et al., 1998) . Some experiments have shown that dietary supplementation with β-glucan reduced growth rate in nonchallenged birds (Huff et al., 2006) ; however, this has not been observed consistently in studies of β-glucans (Chae et al., 2006; An et al., 2008 , Morales-López et al., 2009 or other yeast components (Santin et al., 2001 ).
Ascorbic acid (or vitamin C) is commonly included in poultry diets to mitigate the negative effects of production stress and aid in immune function. Antioxidants, including ascorbic acid, act in opposition to reactive oxygen species, preventing activation of NF-κB-mediated inflammation (Conner and Grisham, 1996) . Heterophils and lymphocytes show enhanced performance in vitro in response to ascorbic acid (Andreasen and Frank, 1999; Panda et al., 2008) , with increases in bacterial killing and pre-and postvaccination antibody titers, respectively. Ascorbic acid reduces the signs of stress in White Leghorn and broiler chickens after temperature stress (Gross, 1992a; McKee et al., 1997; Sahin et al., 2003; Panda et al., 2008) . Deficient ascorbic acid production diminishes the capacity of peripheral white blood cells of swine to react to lipopolysaccharide and other immune stimulants (Schwager and Schulze, 1998) and is associated with higher production of proinflammatory cytokines, presumably mediated by NF-κB signaling. Dietary ascorbic acid lessens the severity of pathologies associated with viral and bacterial disease in chickens (Gross, 1992a; Wu et al., 2000) .
The spleen was selected for immune gene expression analysis because of its roles in leukocyte maturation and activation and production of chemotactic and inflammatory factors. Interleukin-4, IL-6, IL-18, macrophage inflammatory protein-1β (MIP-1β, also CCLi2), interferon-γ (IFN-γ), and phosphoinositide 3-kinase (PI3K)-p110γ were of interest due to their roles in responding to or processing the dietary immunomodulators under study. The balance of T-helper type 1 versus T-helper type 2-mediated immune response in birds is reflected in the characteristic cytokine levels (Staeheli et al., 2001 ); IFN-γ and IL-4, respectively, were chosen for this analysis. The production of IFN-γ is regulated upstream by IL-18 in the chicken (Göbel et al., 2003) . The MIP-1β signals regulate movement of monocytes and T lymphocytes (Sherry et al., 1988) ; therefore, changes in expression could cause changes in splenic cell populations. It has been found that PI3K generates molecules involved in directed movement of leukocyte cell membranes in chemotaxis and phagocytosis (Heit et al., 2008) and has been implicated in the dectin-1-mediated response to β-glucans in mice (Shah et al., 2009 ).
MATERIALS AND METHODS

Experimental Birds
Birds came from outbred broiler and highly inbred Leghorn (Ghs-6) and Fayoumi (M15.2) lines maintained at Iowa State University (zhou and Lamont, 1999; Redmond et al., 2009 ). The broiler and Leghorn lines are characteristic of birds selected for commercial meat and egg production, respectively. The Fayoumi line originated in Egypt and is a nonselected indigenous breed. Experimental birds came from 6 replicate hatch groups, with equal representation of each genetic line within each hatch group, and were tagged at hatch to identify individuals. Chicks received no vaccinations and were housed by hatch group and line in floor pens (n = 8 birds/pen) with ad libitum access to commercial broiler starter feed and water. At 56 d of age, 48 birds per line were randomly assigned to each experimental diet treatment (n = 576 total). Line × diet treatment groups were housed in floor pens with ad libitum access to feed and water during the trial period. Pen location within the room was randomly assigned for each new replicate group.
Dietary Treatments
The basal diet was formulated to meet all NRC (1994) requirements. Immune-modulating diets added 0.1% β-glucans (MacroGard, Immunocorp AS/Biotec Pharmacon ASA, Tromsø, Norway), 0.1% ascorbic acid (ROVIMIX Stay-C 35, DSM Nutritional Products, Basel, Switzerland), or 0.01% corticosterone (anhydrous corticosterone, Sigma-Aldrich, St. Louis, MO) to the basal diet (Table 1 ). The β-glucan and ascorbic acid diets were fed for the full 3-wk experimental period (56 to 77 d of age). The corticosterone treatment was terminated at 2 wk, when severe growth depression and some mortality were observed, and birds in this treatment group were fed the basal diet for the final week of the experiment. Individual BW and treatment group feed consumption (by pen) were measured weekly. Body weight information from all 6 replicate hatches was included in this analysis, whereas a subset of birds was selected at the time of euthanization for gene expression assays.
Gene Expression Assays
Fifty-seven individuals from 2 replicate hatches were selected for gene expression analysis (Table 2) . This group included more birds from the broiler line than from the Fayoumi or Leghorn lines due to the outbred background of the broiler line. At 77 d of age, the birds were killed by cervical dislocation and spleen samples were immediately collected and placed in RNALater (Ambion, Austin, TX), then stored at −70°C until RNA isolation. Splenic tissue from each individual was homogenized and RNA was isolated using the RNAqueous kit (Ambion) as previously described (Abasht et al., 2008) . Isolates were treated with DNAfree (Ambion) and adjusted to a concentration of 50 ng/μL in RNase-free water. Quantitative PCR were performed in triplicate for each sample using the Quantitect SYBR-Green kit (Qiagen, Waltham, MA) using previously reported primers for IL-4 (AJ621735, Avery et al., 2004) , IL-6 (AJ250838, Kaiser et al., 2000) , IL-18 (AJ276026, Kaiser et al., 2003) , MIP-1β (AJ243034, Withanage et al., 2004) , IFN-γ (Y07922, Kaiser et al., 2003) , and the 28s ribosomal RNA. Novel primers were designed with Primer3 (Rozen and Skaletsky, 2000) to amplify a 158-bp region of PI3K-p110γ (forward: 5′-GGACCCCTGGTGATAGAAAA-3′ and reverse: 5′-TGTAAAATAAGCATGTCCTGACG-3′). Each reaction consisted of 50 or 75 ng of total RNA, 12.5 μL of SYBR Green mix, 0.25 μL of RT mix, and 1 μL of each primer and nuclease-free water to a total volume of 25 μL. Reactions were run for 30 min at 50°C, 15 min at 95°C, and were cycled 40 times through 15 s at 94°C, 30 s at 59°C, 30 s at 72°C, and a plate read.
Statistical Analysis
Growth and gene expression data were analyzed using PROC MIXED in SAS (SAS Institute, Cary, NC). Analysis of weight gain included line, diet, sex, and interaction of line and diet as fixed effects and hatch as a random effect. Cycle threshold (Ct) values for gene 
RESULTS AND DISCUSSION
Weight Gain
Within-line average weight gains for each diet treatment are reported (Table 3) . At all measurements after initiation of the diet treatments (d 7, 14, and 21 of trial; d 63, 70, and 77 of age, respectively), BW gain was significantly lower in the corticosterone groups than in any other treatment group (P < 0.001 for all tests). This was expected because this treatment mimicked stress, and birds fed the corticosterone diet consumed less feed than birds fed any of the other diets. There was no significant difference within line in BW of the birds fed the basal diet or the ascorbic acid or β-glucan diets, which supports findings from other studies that low doses of dietary β-1,3/1,6-glucans do not alter growth in broilers under normal conditions (Chae et al., 2006; Morales-López et al., 2009) . Dietary supplementation with yeast-derived β-glucans alleviates the reduction in BW gain associated with challenge of broiler chicks with E. coli (Huff et al., 2006) but not challenge of White Leghorn chicks with Salmonella Enteritidis (Chen et al., 2008) . Broilers supplemented with dietary ascorbic acid showed increased weight gain at 21 and 42 d of age and improved feed utilization under heat stress (Sahin et al., 2003) compared with nonsupplemented birds. The current experiment used older birds, starting at 56 d of age, which were later in their growth phase, a time at which the dietary supplementation may have provided less benefit.
Gene Expression
The mean expression levels, by genetic line and diet treatment group, of IL-4, IL-6, and IL-18 are presented in Table 4 . Splenic mRNA expression levels of MIP-1β, IFN-γ, and PI3K were not affected significantly by diet, genetic line, sex, or the genetic line × diet interaction in the present study, so expression data for these genes has not been included. Expression of IL-18 was significantly affected by sex (P = 0.01), with higher expression levels in males than in females. Although sex has been found to have some influence over inflammation in mammals, this finding in the current experiment is likely an artifact of the data set.
Expression of IL-4, IL-6, and IL-18 showed significant genetic line × diet interactions (P = 0.021, 0.006, and 0.026, respectively). This interaction was most notable in the expression of IL-6, which was significantly lower in the spleens of Leghorns fed β-glucans or corticosterone than in spleens of Fayoumis fed the same diets. In contrast, Leghorns fed the basal or ascorbic acid diets expressed high levels of IL-6 in the spleen and Fayoumis fed these diets expressed low levels of splenic IL-6. Expression of IL-6 is associated with an inflammatory response to pathogen-associated stimuli, such as lipopolysaccharide (Xie et al., 2001) , and the differences observed in the present study suggest that Leghorns had a reduced potential for splenic inflammatory response when fed β-glucans or corticosterone, and Fayoumis had less potential for inflammation under the basal and ascorbic acid diets. The divergence in IL-6 expression between these lines likely reflects a difference in the dominant immune mechanisms used by Table 3 . Body weight gain (in kg) during trial period from 56 to 77 d of age by diet and genetic line Leghorn and Fayoumi birds, which may have been augmented by the diet treatments. Previous studies have shown that these lines differ in early proinflammatory response to Salmonella Enteritidis, with higher expression of chemokines (CXCLi2 and MIP-1β) and IL-12α in the spleen of 1-d-old Leghorns compared with Fayoumi chicks (Cheeseman et al., 2007) and higher expression of IL-6, IL-10, transforming growth factor-β4, and granulocyte macrophage colony-stimulating factor by isolated Fayoumi heterophils stimulated in vitro compared with stimulated Leghorn heterophils (Redmond et al., 2009) .
Line × diet interactions for IL-4 and IL-18 followed a different pattern than that of IL-6. Chickens from Leghorn and Fayoumi lines had the highest splenic IL-4 levels when fed the ascorbic acid diet, although this was only significant in the Fayoumi line. Interleukin-4 is characteristic of a T-helper type 2-mediated immune response, and this change in expression could reflect a shift to favor this type of response in the Fayoumi birds fed ascorbic acid. Expression of IL-18 was influenced by diet in the Fayoumi line only, which showed higher levels of splenic IL-18 associated with the β-glucan-enhanced diet than with the basal or ascorbic acid diets; however, there was no corresponding difference in IFN-γ, which can be induced by IL-18 (Göbel et al., 2003) . The lack of a significant diet effect on IFN-γ supports an increase in T-helper cell number rather than an augmentation of the T-cell-mediated immune response.
The broiler line, surprisingly, did not show any significant change in splenic gene expression in response to the immune-modulating diets. The intense selection for growth in broiler chickens may have reduced their ability to alter expression of genes involved primarily in immune function rather than growth. Alternatively, the 3-wk period between initiation of the diet treatments and sampling of splenic tissue may have allowed for a transient response that was not detected in this experiment. Other studies of the broiler response to dietary β-glucans have shown that the distribution of lymphocyte subsets (Chae et al., 2006) and relative weights of the spleen and bursa of Fabricius (Morales-López et al., 2009) did not respond to dietary supplementation with β-glucans in healthy birds. The benefits of β-glucan or ascorbic acid supplementation are evident in broilers and turkeys subjected to stress or infection 18.9 ± 0.5 a,y β-Glucans 26.8 ± 0.9 a,x 13.6 ± 1.2 a,x 19.5 ± 0.5 a,z Ascorbic acid 26.5 ± 0.9 a,y 12.9 ± 1.5 a,x 18.4 ± 0.6 a,y Corticosterone 29.3 ± 1.3 a,x 13.3 ± 1.6 a,x 18.8 ± 0.6 a,z Leghorn Basal 28.0 ± 1.0 a,x 17.6 ± 2.0 a,y 23.2 ± 0.8 a,x β-Glucans 26.8 ± 0.9 a,x 12.8 ± 1.8 b,x 22.9 ± 0.7 a,y Ascorbic acid 28.1 ± 0.9 a,xy 18.6 ± 2.0 a,y 24.8 ± 0.8 a,x Corticosterone 26.6 ± 0.9 a,x 12.0 ± 1.7 b,x 22.6 ± 0.7 a,y Fayoumi Basal 28.1 ± 0.9 a,x 8.0 ± 2.0 b,z 22.4 ± 0.8 b,x β-Glucans 24.9 ± 1.0 b,x 14.7 ± 2.0 a,x 26.0 ± 0.8 a,x Ascorbic acid 30.2 ± 1.3 a,x 6.5 ± 2.6 b,z 22.2 ± 1.0 b,x Corticosterone 27.6 ± 0.9 ab,x 14.2 ± 1.6 a,x 23.5 ± 0.6 ab,xy a,b Different superscripts indicate a significant difference in expression by diet within each line (P < 0.05).
x-z Different superscripts indicate a significant difference in expression by line within each diet (P < 0.05). 1 IL = interleukin. 2 P-value for each main effect (line or diet) or interaction is listed in parentheses for each gene. (McKee et al., 1997; Sahin et al., 2003; Huff et al., 2006 Huff et al., , 2010 . We hypothesize that the partitioning of energy toward growth in broilers (Lamont et al., 2003) masks dietary augmentation of the immune response in the absence of a specific pathogen or stressor; however, we cannot rule out the occurrence of changes that may be detectable at times and ages not assessed in the present experiment.
The results of the current study indicate that the addition of immune-enhancing substances to chicken diets may have different effects due to the genetic backgrounds of the lines. This has important implications for producers interested in using alternatives to subtherapeutic antibiotics to maintain health and growth in their flocks because treatments proven effective in one type of chicken may not have the same beneficial effect in other lines.
